Oil nearing $120 a barrel for first time since 2022 as Trump maintains Iranian blockade – as it happened
Rolling coverage of the latest economic and financial news, as Brent crude approaches highest level since Middle East conflict began
www.silverguide.site –
Brent crude highest since June 2022
Newsflash: oil has now hit its highest level in almost four years, after Donald Trump signalled that he will maintain the US blockade on Iranian ports.
The Brent crude oil price hit $119.76 a barrel a few minutes ago, breaking above its previous high of $11.90 set in the early weeks of the Iran war.
Oil is also being pushed up by data showing a drop in US crude oil inventories.
The United States became a net exporter of crude for the first time since World War Two as the country shipped a record volume of oil to refiners scrambling for supplies after the Iran war, leading to large drops in domestic inventories, the Energy Information Administration said today.
Brent crude over $119 as Trump sticks with blockade
A late update: Oil is now approaching its highest level since the Iran war began.
Brent crude has risen over $119 a barrel, up 7% today, after president Donald Trump told Axios he will not lift a naval blockade of Iran’s ports until he secures a deal with Tehran to address the country’s nuclear program.
This decision extends the ongoing standoff over the Strait of Hormuz that has caused a global energy crisis.
Trump said in a phone interview Wednesday, according to Axios:
“The blockade is somewhat more effective than the bombing. They are choking like a stuffed pig. And it is going to be worse for them. They can’t have a nuclear weapon,”
Updated
Closing post
Time to wrap up…
Oil and gas prices have jumped, following reports that the US has discussed extending its blockade of Iranian ports for months.
The UK government has asked British refineries to maximise jet fuel supply, as part of its contingency planning to maintain supplies.
The Middle East conflict has knocked UK exports to the region down by a fifth.
Lloyds Bank has taken a £151m charge to cover the economic damage of the Iran war.
Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year.
It said it would invest in two existing locations, unfreezing a paused £200m expansion in Cambridge and pouring £100m into its Macclesfield site.
Updated
Britain’s stock market has ended the day at its lowest close since 31 March.
The FTSE 100 index has dropped by 119 points, or 1.16%, to finish at 10,213 points, its seventh daily fall out of the last eight sessions.
Back in the markets, UK borrowing costs are rising as the jump in oil and gas prices threatens to push up inflation.
The yield, or interest rate, on two-year UK gilts has hit its highest level since laste March, up 13 basis points (0.13 percentage points) at 4.58% today.
Reuters has spotted that the money markets are almost fully pricing in three increases in UK interest rates this year – we’ll hear from the Bank of England at noon tomorrow, when it’s expected to leave rates on hold….
Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry (ABPI), is also cheered by AstraZeneca’s plan, saying:
“AstraZeneca’s decision to resume and even boost the £300m expansion of its Macclesfield and Cambridge research campus, and Boehringer Ingelheim’s launch of a new £150m artificial intelligence accelerator in King’s Cross, are both powerful signals that the UK’s position as a global destination for life sciences investment is being restored. Together, they represent nearly half a billion pounds of commitment to research that will help find new medicines for patients.
“Just six months ago, the picture looked very different. Several major companies had paused or withdrawn significant investments, citing a UK environment that was not internationally competitive. The UK-U.S. pharmaceutical arrangement reached in December, and particularly the increase to the NICE baseline cost-effectiveness threshold, has begun to shift how industry sees the UK.
“When companies believe that the medicines they develop will be properly valued and made available to NHS patients, they invest. While there is more to do, we are starting to see that positive feedback loop that we’ve all been trying to achieve.”
The Association of the British Pharmaceutical Industry said it had been a “remarkable month for UK life sciences”, culminating in AstraZeneca’s investment.
Since the UK-US drug pricing deal, companies have invested £1.4bn in UK life sciences, including £500m by Belgium’s UCB and $500m (£370m) by Bristol Myers Squibb of the US.
Analyst: Long-term blockade would test markets
Anyone hoping for the blockade to come to an end this week has been “deeply disappointed”, points out Kathleen Brooks, research director at XTB.
The latest news from the White House suggests that President Trump is looking at measures to maintain the blockade for an extended period if necessary. The President met with oil company executives, presumably to boost US refinery production, especially for diesel and jet fuel. Financial markets will now need to price in the prospect of a prolonged blockade. This is obviously impacting on the oil price, which is higher by nearly 10% in the past 5 sessions. It could also lead to higher futures prices, as the market adjusts to a long-term closure of the Strait.
We assume the President wants US oil companies to boost production, however, if US oil refineries focus on ramping up production of jet fuel and diesel, it could reduce output of other products, which may lead to broader inflationary pressures for the global economy. This is a new phase of the war in Iran, and we could now see oil prices go back to the March highs around $120 per barrel for Brent.
As always with President Trump, his rhetoric on Truth Social may not reflect reality. The President has also urged Iran to sign a deal to end the US blockade. The US is using the blockade to squeeze Iran, we will now find out how long they can hold out.
If this is a long-term blockade, we will find out whether financial markets are underpricing the risks of the war in the Middle East.
The London stock market is extending its earlier losses, as concerns mount about the lack of progress to end the Iran war.
The FTSE 100 share index is now down 126 points, or 1.2%, at 10,206 points, its lowest level since 1 April.
Updated
Oil and gas prices jump on reports US will extend blockade of Iranian ports
Back in the energy markets, oil and gas prices are pushing higher amid worries that the US blockage of Iran may drag on for months.
Brent crude is up 5% at almost $117 a barrel, close to the highest level set since the Iran war began ($119.50 a barrel).
The UK month-ahead gas price is up 5% at 113.86p a therm, while the benchmark Dutch front-month contract was up 5.35% at €45.93 per megawatt hour (MWh)
Energy prices rose following reports that U.S. President Donald Trump met with top officials from energy companies on Tuesday to talk about steps that could be taken to calm oil markets if it is necessary to continue the blockade of Iranian ports for months, a White House official said on Wednesday.
The talks centered on U.S. oil production, oil futures, shipping and natural gas, the official said (via Reuters).
AstraZeneca’s decision to invest £300m in the UK is “super encouraging”, says Susannah Streeter, chief investment strategist at the Wealth Club, suggesting momentum is returning to pharmaceutical industry in the UK.
The restart of the Cambridge expansion, as part of a £300m UK investment package, is highly symbolic. It demonstrates how the government has been working hard behind the scenes to try and make the UK more attractive to big pharma, following the shock announcement of the project being mothballed. There is set to be higher spending on medicines and a more accommodating pricing framework, helping ensure the UK is no longer seen as a low-price outlier compared to global peers.
The tariff environment has also shifted which is also likely to be behind this move. With the row over the legitimacy of Donald Trump’s tariffs ending up in the courts, the immediate potency of US trade policy has been diluted. More importantly, a targeted agreement between the United Kingdom and the United States is set to give UK-made drugs a tariff-free route into the US market for the next few years, insulating exporters from the worst of the remaining threats.
Even so, this needs to be put into perspective, as the UK investment pales in comparison with the tens of billions of dollars being poured into production facilities across the US and China.”
Over in the US, new housebuilding construction has hit its highest level in a year.
Housing starts increased 10.8% to an annual rate of 1.5 million homes in March, the highest since December 2024, according to figures released Wednesday by the Census Bureau.
The data suggest that US homebuilders boosted production despite ongoing affordability concerns, fuelled by the Iran war.
Thomas Ryan, North America Economist at Capital Economics, says home construction picked up as “harsh winter conditions gave way to an unseasonably warm start to Spring”, adding:
Positively, this strength was driven by a 15% increase in single-family starts to 1.03m annualised – their highest in over a year – while starts in the typically volatile multi-family segment whipsawed. Based on the weakness in forward-looking permits data and homebuilder confidence, we do not expect this strength to last.
Full story; AstraZeneca's u-turn
Science Secretary Liz Kendall has welcomed AstraZeneca’s plan, saying:
“This investment is another significant vote of confidence in our science community and backs British research to do what it does best - develop the drugs, treatments, and innovations that improve lives.
“AstraZeneca’s investment will protect and create jobs and underlines the excellence and expertise of this country’s world-leading life sciences sector. Alongside the partnership we agreed with the United States earlier this month, this is how we are delivering real innovation that will transform outcomes for patients here at home and around the world.”
AstraZeneca is planning to create new R&D jobs in Macclesfield through its new funding, but was unable to say how many.
In Cambridge, the company will move people from several other buildings into the new Rosalind Franklin office building, including scientists who do data analysis and statistics and molecular scientists who do desk based work.
Although the £300m of funding is not to be sniffed at – especially if you’re a prime minister desperate for some good news – it is dwarfed by some of AstraZeneca’s other investments recently.
Last July, AstraZeneca announced it will invest $50bn (£37bn) in the US by 2030, after Donald Trump threatened the pharmaceuticals industry with hefty new tariffs on drugs made abroad.
Then in January, it pledged $15bn of investment in China, during a visit by Keir Starmer to the country.
The £300m of new funding from AstraZeneca is made up of the paused £200m project in Cambridge and £100m new money for the “lab of the future” in Macclesfield.
The expansion of its Cambridge research site will be named after Rosalind Franklin, the English chemist whose X-ray crystallography work was vital to cracking the structure of DNA.
The building is near the Disc, the AZ headquarters, in Cambridge.
CEO Pascal Soriot told reporters:
“We thought it was only fair to to represent the contribution of a great, female scientist to the discovery of DNA. And that’s the background for the name of this building.”
It’s notable that Keir Starmer credited his pharmaceuticals deal with the US for persuading AstraZeneca to invest £300m in the UK.
That transatlantic agreement is controversial, as it involves the UK paying 25% more for new medicines by 2035.
But it also means British drug exports to the US will escape tariffs imposed by Donald Trump, and will also give patients in Britain greater access to potentially life-extending drugs.
AZ's Soriot thanks government
Pascal Soriot, AstraZeneca’s chief executive, has thanked the UK government “for their effort to improve access for patients, including four new [drug] approvals since the beginning of the year, and we look forward to further enhancing the access and the reimbursement environment and build a strong life sciences sector”.
AstraZeneca investing £300m in UK, Starmer announces
Newsflash: Pharmaceuticals group AstraZeneca is investing £300m in its UK operations, Sir Keir Starmer has announced.
Starmer revealed the plan to MPs during prime minister’s questions, seven months after AstraZeneca paused a planned £200m expansion of its Cambridge research site.
Starmer said the move would protect jobs in Cambridge, where AstraZeneca operates a global R&D facility, and in Macclesfield, which hosts a science, technology and manufacturing hub and is the company’s second largest manufacturing site.
Starmer told the House of Commons:
Today I can announce a significant new investment, by AstraZeneca, investing £300m in UK life sciences, made possible by the pharmaceutical arrangement we have struck with the United States, to future-proof thousands of jobs in Macclesfield and in Cambridge.
That is a major vote of confidence in the UK, and Labour’s plans to strengthen our economy.
Last September, AstraZeneca halted a planned £200m expansion of its Cambridge research site, which was seen as a blow to the UK pharmaceutical industry.
In January 2025, the company scrapped plans to invest £450m in its vaccine manufacturing facility in Merseyside, and blamed a cut in the funding on offer from the government.
Updated
UK has asked refineries to maximise jet fuel supply, minister says
Britain has asked UK refineries to maximise jet fuel supply as it continues to plan for a range of contingencies to increase flexibility on supply, the government said on Wednesday.
Energy minister Michael Shanks told MPs that the government has been “closely monitoring UK jet fuel stocks” since the closure of the strait of Hormuz last month, and is working with airlines, airports, fuel suppliers and international counterparts.
In a written answer, Shanks explained:
The Government continues to plan for a range of contingencies to increase flexibility on jet fuel supply, we have asked UK refineries to maximise jet fuel supply.
Airport Coordination Limited has updated its guidance to allow airlines to apply for slot alleviation, providing greater flexibility to plan flights. I encourage all passengers to check their rights before travelling and in the first instance to contact their airline, travel agent or tour operator where they have concerns.
We have published a fact sheet on GOV.UK that will be kept updated, alongside Foreign, Commonwealth and Development Office travel advice.
Shanks also points out that UK airlines typically buy fuel months in advance, and that aviation fuel suppliers hold bunkered stocks.
The UK also imports jet fuel supplies from a range of countries not reliant on the strait of Hormuz being open, including the United States, he adds, pointing out:
Airlines UK have stated that “UK airlines continue to operate normally and are not experiencing issues with jet fuel supply.” The Government continues to work with partners to monitor and mitigate potential disruptions.
Earlier this month, the head of a global energy watchdog warned that Europe only had six weeks of jet fuel left before shortages will hit because of the Iran war.
In the short-term, the UAE’s exit from Opec will have little impact on the oil price as the ongoing blockade of the strait of Hormuz is governing supplies, and thus price.
But in the longer-term, it could have significant consequences for the oil market, if it weakens the cartel’s grip on price action.
Lukman Otunuga, head of market research at global trader FXTM, explains:
The UAE’s departure is described as a major blow to OPEC and could reshape global energy market dynamics
Near-term oil market impact is limited while the Strait of Hormuz remains closed
Longer-term implications are bearish; if more members leave and pump without production caps, oil supply could surge
Brent crude remains at triple digits as markets await Washington’s response to Tehran’s peace proposal
Russia hopes UAE exit does not spell the end of OPEC+, and pledges to stay put
Russia is hoping that yesterday’s shock news that the United Arab Emirates is leaving the Opec+ group doesn’t prompt the end of the alliance.
Kremlin spokesman Dmitry Peskov said today that Russia will stay in Opec+, and hopes it will continue, Reuters reports.
Peskov argued that Opec+ played an important role, saying:
“This format helps to substantially, let’s say, minimise fluctuations in energy markets and makes it possible to stabilise those markets”.
The UAE sent shockwaves through the oil sector yesterday by announcing it was will quit the Opec oil cartel on Friday, in a heavy blow to the group and its de facto leader, Saudi Arabia
The shock loss of the UAE, Opec’s third-largest oil producer, is expected to weaken the group, which for decades has worked together to use its collective oil production to influence global oil market prices by setting quotas for its members.
Russia is a powerful member within Opec+, which is made up of Opec and its allies.
UAExit, as some wags have dubbed it, is a win for Donald Trump, who has previously accused Opec of “ripping off the rest of the world” by artificially inflating oil prices by holding back production.
Analysts have been speculating about which other Opec members could follow the UAE. Marketwatch reports that “Kazakhstan and perhaps Iraq” are seen as the two countries most likely to leave the oil bloc’s sphere.
Updated
Best case scenario for Iran war? £35bn off UK GDP
The Iran war will knock £35bn off the size of the UK economy over 2026 and 2027, in a “best case” scenario where hostilities end soon.
That’s according to the National Institute of Economic and Social Research’s latest quarterly Economic Outlook, released this morning.
NIESR predicts that UK growth will stall in the second half of the year, as the Middle East conflict has “materially weakened the UK outlook” by pushing up global energy prices, raising inflation and reducing household spending power.
David Aikman, NIESR director, says:
“This is a serious blow to the government’s mission to get the UK economy growing again.
The Middle East conflict has laid bare the fact that the UK remains highly exposed to global energy shocks. Even if hostilities ease rapidly, higher energy prices will leave households poorer, businesses facing higher costs, and the economy materially smaller than we expected only a few months ago.”
Difficult to get Adidas goods into Middle East due to war, CEO says
The CEO of Adidas has revealed the company has faced difficulties getting products into the Middle East due to the Iran war.
Bjørn Gulden told reporters this morning:
“I don’t think we have any clear disruption now [due to the war], unless, of course, it’s difficult to get products in the Middle East.”
Gulden also flagged that transportation costs are “starting to explode” due to a surge in oil price – so he won’t be happy to see Brent crude up 3% this morning.
He was speaking after Adidas reported a rise in sales in the last quarter, with revenues up 14% and operating profits rising by 16%.
EU economic sentiment tumbles
Economic confidence and employment expectations have punged across the European Union this month, as consumer confidence is hit hard by the Iran war.
The European Commission’s Economic Sentiment Indicator for the EU dropped by 2.9 points this month to 93.5 points, while its Employment Expectations Indicator fell by 4 points to 93.2, both below their long-term averages.
The decline of the ESI was driven by plummeting confidence among EU consumers, as well as managers in services and retail trade, while confidence in construction and industry held up broadly stable.
The EC adds:
Among the largest EU economies, the ESI deteriorated significantly in Germany (-3.9), France (-3.0), Italy (-2.8) and the Netherlands (-2.5), while it decreased less dramatically in Spain (-0.9) and Poland (-0.8).
DCC receives takeover approach
Irish international sales, marketing and support services group DCC has received a takeover approach, sending its shares up 14%.
DCC has told the City that it has received an “indicative cash proposal” from a consortium made up of investment firms Energy Capital Partners, and Kohlberg Kravis Roberts.
It added:
The Board of DCC is evaluating the Proposal together with its advisers and a further announcement will be made in due course.
There can be no certainty that any firm offer will be made for the Company, nor as to the terms on which any firm offer might be made. Shareholders are urged to take no action at this time.
Shares in DCC, which has been valued at £4.6bn before the annoucement, have jumped to the top of the FTSE 100 risers.
Updated
Oil is pushing higher… it’s now hit $115 a barrel, a rise of 3.3% today.
Today’s reports that “President Trump has instructed aides to prepare for an extended blockade of Iran” creates additional challenges for the Bank of England’s MPC and other central banks.
Professor Costas Milas, of the University of Liverpool’s Management School, explains:
This is because quantitative (or econometric) models of the UK economy (and other economies) usually find a small impact of oil prices on UK inflation.
In other words, forecasts provided by tomorrow’s Monetary Policy Report are likely to underestimate inflation even if the MPC assumes oil prices of $120-$150 for six (or more) months. It will be good if the MPC also focuses on the global supply chain pressure index of the Fed of New York to provide alternative and arguably more reliable inflation forecasts!
The jump in energy prices this month has pushed up inflation in three German states this month.
In Bavaria, the inflation rate rose in April to 2.9% from 2.8% in the previous month. In Lower Saxony, it accelerated to 3.0% from 2.6%, and in Baden-Wuerttemberg to 2.6% from 2.5%.
In North Rhine-Westphalia, the consumer price index stood unchanged at 2.7%.
These readings suggest Germany’s headline inflation rate will also rise this month.
Oil at one month high as Trump plumps for 'extended blockade of Iran'
The oil price has hit its highest level in a month, following reports that President Trump has instructed aides to prepare for an extended blockade of Iran.
Brent crude has risen by 1.8% this morning to above $113 a barrel, the highest since 31 March, a week before the US-Iran ceasefire was agreed.
Crude prices rose after the Wall Street Journal reported that Trump has decided to target Tehran’s coffers by squeezing Iran’s economy and restricting oil exports by preventing shipping to and from its ports, in an attempt to force it to dismantle all its nuclear work.
The WSJ reports:
He assessed that his other options—resume bombing or walk away from the conflict—carried more risk than maintaining the blockade, officials said.
Yet continuing the blockade also prolongs a conflict that has driven up gas prices, hurt Trump’s poll numbers and further darkened Republicans’ prospects in the midterm elections. It has also caused the lowest number of transits through the Strait of Hormuz since the war began.
Brent crude had been trading around $70 a barrel before the conflict began, before hitting $119.50 a barrel in mid-March.
FTSE 100 lowest since 1 April
Britain’s main stock index has dropped to its lowest level in almost a month, on a busy morning for corporate news.
The FTSE 100 share index dropped by 52 points, or 0.5%, in early trading to 10,280 points, its lowest level since 1 April.
Wealth manager St James’s Place are the top faller, down 6.3%, after reporting a drop in net inflows in the first quarter of 2026 amid “heightened geopolitical uncertainty and market volatility”.
British drugmaker GSK are down 2.7%, after reporting first-quarter profit and sales above analysts’ expectations. Fellow pharmaceuticals giant AstraZeneca (1%) are also among the fallers, despite beating profit expectations this morning thanks to strong demand for its cancer and rare-disease drugs.
Meta now has the chance to examine the commission’s investigation file and mount a defence against the charge that it has breached of EU law for failing to prevent children under 13 from using its Facebook and Instagram platforms.
If the finding against the Silicon Valley company is upheld, it could be fined up to 6% of its global annual turnover. Meta reported revenue of $201bn (£148bn) for 2025.
EC: Meta failing to prevent minors under 13 from using Instagram and Facebook
Newsflash: The European Commission has preliminarily found Instagram and Facebook in breach of Europe’s Digital Services Act (DSA) for failing to protect minors.
The EC says the two services, both owned by Meta, failed to “diligently identify, assess and mitigate the risks of minors under 13 years old accessing their services”.
It is proposing that Instagram and Facebook must change their risk assessment methodology, and strengthen their measures to prevent, detect and remove minors under the age of 13 from their service.
In a statement outlining its preliminary findings, the EC says there are no effective controls to prevent a minor below the age of 13 from entering a false birth date, and labels Meta’s tool for reporting minors under 13 on the platform as “difficult to use and not effective”
Henna Virkkunen, executive vice-president for Tech Sovereignty, Security and Democracy, says:
Meta’s own general conditions indicate their services are not intended for minors under 13. Yet, our preliminary findings show that Instagram and Facebook are doing very little to prevent children below this age from accessing their services. The DSA requires platforms to enforce their own rules: terms and conditions should not be mere written statements, but rather the basis for concrete action to protect users – including children.
Elsewhere in banking, Santander UK is taking an extra £179m provision to cover the cost of the motor finance scandal.
The charge has pulled Santander UK’s pre-tax profits in Q1 2026 down to £202m, from £358m a year earlier.
It also lifts the company’s total provision to £633m, which is ‘at the upper end of the previously assessed range.’
This comes after the Financial Conduct Authority issued its plans for a compensation scheme for customers who were overcharged for loans when buying a car, due to commission payments between lenders and car dealers between 2007 and 2024.
Santander UK has decided not to challenge the scheme, and has updated its scenarios and assumptions including operational and legal costs. However, the FCA’s proposals is now being challenged by Consumer Voice, who argue it does not compensate enough customers affected.
Lloyds profits jump despite £151m impairment charge from Middle East conflict
Lloyds Banking Group has shrugged off the economic uncertainty caused by the Iran war, by beating profit expectations for the first three months of the year.
Earnings at Lloyds jumped by a third in the first three months of 2026 to £2bn, up 33% compared with a year ago, and ahead of analyst forecasts of £1.8bn.
Lloyds chief executive Charlie Nunn said the banking group’s business model was “resilient in the context of the current economic uncertainties”, adding:
“We remain focused on supporting UK households and businesses as they look to strengthen their financial positions and achieve their goals.”
Lloyd also took a £151m impairment charge to reflect “the deterioration in economic outlook as a result of the Middle East conflict”. However, that was partly countered by a £50m improvement in “global tariff and political disruption risks”.
The uncertainty over the Middle East conflict means many holidaymakers are delaying their bookings until closer to departure time.
Jet2, the flights and package holiday firm, has reported this morning that since the conflict began, its customers’ “booking profile has become increasingly close to departure”, adding:
At present, Q1 (April, May, June) combined average load factor is in line with the prior year, with the current geopolitical uncertainty limiting visibility for the peak summer season and beyond.
As previously stated, we continue to invest in load factor and remain fully committed to pricing that is attractive and represents real value to our Customers.
Passenger bookings for summer 2026 are up 6.2% compared with the previous year, while Jet’s capacity is currently 7.7% higher than in summer 2025.
The company adds that it has ‘a high degree of cost certainty’ about its jet fuel costs, as it has hedged 87% of its summer requirements.
Heathrow has warned that it faces an ‘uncertain outlook’, after a positive start to the year.
London’s largest airport has reported a 3.7% rise in passengers in the first quarter of this year, up to 18.9m.
It says:
Following airspace closures in the Middle East, there was an increase in transfer passengers across Heathrow’s network. While Heathrow has temporarily absorbed demand from elsewhere, passenger numbers for the rest of the year are likely to be impacted whilst there is significant uncertainty in the Middle East.
Heathrow adds that it has “seen some impact from recent Middle East disruption”, but has not yet updated its outlook for 2026.
Updated
More UK firms fall into financial distress
The number of UK businesses in “critical financial distress” has jumped by more than a third amid fresh pressure linked to the conflict in the Middle East, according to new research.
Hotels and leisure firms are in particular distress after facing higher labour costs and taxes over the past year, latest research from Begbies Traynor Group (BTG) has shown.
BTG’s latest quarterly red flag report indicated that more firms edged closer to collapse in the first quarter of 2026 – the number of companies considered in “critical financial distress” rose by 36.9% to 62,193 for the quarter, compared with the same period a year earlier.
The number of businesses in “significant” financial distress meanwhile rose by 9.6% year on year to 634,867.
Ric Traynor, executive chairman of BTG, said:
“The shockwaves from a war in the Middle East will be felt across every corner of the global economy for some time to come.
After initial signs that the UK’s GDP was improving at the very start of the year, it now feels like after taking a step forward, the UK has taken a few steps backwards following one of the most severe energy shocks in living memory.”
Introduction: UK exports to Middle East drop 20 % since war began
Good morning, and welcome to our rolling coverage of business, the financial markets, and the world econony.
UK trade to the Middle East has shrunk since the Iran war began eight weeks ago, new data shows.
The British Chambers of Commerce has reported that the number of certificates of origin issued by Chambers of Commerce for exports to the region fell by 20% year-on-year in March, down from 15,437 in March 2025 to 12,360 in March 2026
This decline indicates goods are either being delayed, rerouted or not shipped at all.
Companies classified as Arab League countries for certificates of origin include Algeria, Bahrain, Comoros, Djibouti, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic, Tunisia, United Arab Emirates and Yemen.
Steven Lynch, director of international trade at the British Chambers of Commerce, says UK firms are dealing with less reliable trade routes, rising costs and geopolitical risks, adding:
“Our documentation data shows a clear and immediate shock to UK trade flows linked directly to disruption across the Middle East. The fact that exports tied to Arab markets are falling far faster than elsewhere tells us this is a targeted, region‑specific impact, not a broad‑based downturn.
“Firms are reporting increased delays, rerouting via longer and more expensive pathways, enduring rising insurance premiums and facing stretched lead times. For SMEs in particular, this squeezes cashflow and confidence at a time when exporting is already challenging.
There’s no let-up in that challenge today, with the strait of Hormuz still badly disrupted and reports that the US is planning for a lengthy blockade of Iranian ports.
According to the Wall Street Journal, US President Donald Trump has instructed aides to prepare for an extended blockade of Iran.
UK companies are already pessimistic about the economic outlook, and expect activity to fall in the next three months according to the CBI’s latest Growth Indicator.
It has found that business volumes in the services and manufacturing sector are anticipated to fall over the quarter,
Alpesh Paleja, CBI deputy chief economist, explains::
“Business’ expectations for activity have weakened further, as companies continue to grapple with uneven trading conditions, strong cost pressures and renewed uncertainty.
“These challenges have been exacerbated by the conflict in the Middle East, which is increasingly hitting a broad swathe of UK businesses. Our surveys suggest that the additional pressure on costs and supply chains is feeding through to pricing intentions – but not nearly enough to offset the burden facing firms.
The agenda
10am BST: Eurozone economic sentiment data
2.45pm BST: Bank of Canada interest rate decision
7pm BST: US Federal Reserve interest rate decision
7.30pm BST: Federal Reserve press conference
Updated

Comment